Page last updated: 2024-10-30

methadone and Allodynia

methadone has been researched along with Allodynia in 36 studies

Methadone: A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3)
methadone : A racemate comprising equimolar amounts of dextromethadone and levomethadone. It is a opioid analgesic which is used as a painkiller and as a substitute for heroin in the treatment of heroin addiction.
6-(dimethylamino)-4,4-diphenylheptan-3-one : A ketone that is heptan-3-one substituted by a dimethylamino group at position 6 and two phenyl groups at position 4.

Research Excerpts

ExcerptRelevanceReference
"Using a prospective, randomized, blinded design, adolescents presenting for posterior spinal fusion to treat idiopathic scoliosis were assigned to receive desflurane with remifentanil alone (REMI), remifentanil + methadone (MET) (0."9.27Analgesic effects of methadone and magnesium following posterior spinal fusion for idiopathic scoliosis in adolescents: a randomized controlled trial. ( Barry, N; Beebe, AC; Bhalla, T; Gill, L; Klamar, J; Martin, DP; Rice, J; Samora, WP; Thung, A; Tobias, JD; Tumin, D; Veneziano, G, 2018)
"The reports on pain perception among former heroin addicts receiving methadone maintenance treatment (MMT) vary with regard to pain and intolerance threshold, and perception of suprathreshold stimuli has not been previously evaluated."7.77The differential effect of methadone dose and of chronic pain on pain perception of former heroin addicts receiving methadone maintenance treatment. ( Adelson, M; Defrin, R; Hetzroni, T; Peles, E; Schreiber, S, 2011)
"Using a prospective, randomized, blinded design, adolescents presenting for posterior spinal fusion to treat idiopathic scoliosis were assigned to receive desflurane with remifentanil alone (REMI), remifentanil + methadone (MET) (0."5.27Analgesic effects of methadone and magnesium following posterior spinal fusion for idiopathic scoliosis in adolescents: a randomized controlled trial. ( Barry, N; Beebe, AC; Bhalla, T; Gill, L; Klamar, J; Martin, DP; Rice, J; Samora, WP; Thung, A; Tobias, JD; Tumin, D; Veneziano, G, 2018)
"Antinociceptive effect of narcotic analgesics, fentanyl, oxycodone and methadone in inflammatory pain state was described in the von Frey filament test using the complete Freund's adjuvant (CFA)-induced mouse inflammatory pain model."3.80Differential alternation of the antinociceptive effect of narcotic analgesics on the inflammatory pain state. ( Aoki, Y; Mizoguchi, H; Sakurada, S; Sakurada, T; Watanabe, C, 2014)
"The reports on pain perception among former heroin addicts receiving methadone maintenance treatment (MMT) vary with regard to pain and intolerance threshold, and perception of suprathreshold stimuli has not been previously evaluated."3.77The differential effect of methadone dose and of chronic pain on pain perception of former heroin addicts receiving methadone maintenance treatment. ( Adelson, M; Defrin, R; Hetzroni, T; Peles, E; Schreiber, S, 2011)
"This observational study aimed to determine whether pain sensitivity in patients with noncancer chronic pain, taking either methadone or morphine, is similar to patients maintained on methadone for dependence therapy, compared with a control group."3.75Hyperalgesia in opioid-managed chronic pain and opioid-dependent patients. ( Bochner, F; Hay, JL; Rounsefell, B; Semple, TJ; Somogyi, AA; White, JM, 2009)
" Chronic intrathecal morphine or methadone significantly increased spinal glial activation (toll-like receptor 4 mRNA and protein) and the expression of multiple chemokines and cytokines, combined with development of analgesic tolerance and pain enhancement (hyperalgesia, allodynia)."3.74Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia. ( Baker, EM; Coats, BD; Hutchinson, MR; Jekich, BM; Judd, CM; Lewis, SS; Maier, SF; Martin, D; Poole, S; Rezvani, N; Somogyi, AA; Sprunger, DB; Watkins, LR; Wieseler, JL; Zhang, Y, 2008)
"Hyperalgesia and allodynia in 4 cancer patients treated with morphine disappeared after discontinuing or substituting morphine with other opioid agonists."3.69Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with other opioid agonists. ( Jensen, NH; Jensen, TS; Sjøgren, P, 1994)
"Interestingly, opioids induce hyperalgesia via many of the same neuro-inflammatory and central sensitization processes that occur with the development of neuropathic pain."2.75Gabapentin improves cold-pressor pain responses in methadone-maintained patients. ( Compton, P; Kehoe, P; Ling, W; Sinha, K; Torrington, MA, 2010)
"Methadone patients were tested over an inter-dosing period: at the time of trough plasma methadone concentration (0 h), and 3 h after their daily dose."2.70Hyperalgesic responses in methadone maintenance patients. ( Ali, R; Bochner, F; Doverty, M; Ling, W; Somogyi, AA; White, JM, 2001)
"Methadone patients were hyperalgesic to pain induced by CP but not ES."2.70Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine. ( Beare, CH; Bochner, F; Doverty, M; Ling, W; Menelaou, A; Somogyi, AA; White, JM, 2001)
"Pharmacological approaches incorporate the continuation of usual medications (or equivalent), short-term use of sometimes much higher than average doses of additional opioid, and prescription of non-opioid and adjuvant drugs, aiming to improve pain relief and attenuate opioid tolerance and/or opioid-induced hyperalgesia."2.47Acute pain management in opioid-tolerant patients: a growing challenge. ( Huxtable, CA; MacIntyre, PE; Roberts, LJ; Somogyi, AA, 2011)
"Opioid-induced hyperalgesia was associated with an increase in the MAC in normal rats who had not undergone surgery."1.42Hyperalgesia and increased sevoflurane minimum alveolar concentration induced by opioids in the rat: a randomised experimental study. ( Abreu, M; Aguado, D; Benito, J; García-Fernández, J; Segura, IA, 2015)
"Methadone is an atypical opioid that inhibits hyperalgesia through NMDA-blockade, especially at low doses."1.39The use of very-low-dose methadone for palliative pain control and the prevention of opioid hyperalgesia. ( Bruera, E; Buckley, JS; Salpeter, SR, 2013)
"Methadone only treated rats had a mean paw withdrawal latency significantly lower than the corresponding values for saline on days 8, 9, 10, 11, 12, 14, and 17 (P<0."1.36Model of methadone-induced hyperalgesia in rats and effect of memantine. ( Hay, JL; Irvine, R; Kaboutari, J; Salem, A; White, JM, 2010)
"The degree of hyperalgesia was greater with l-methadone compared with d,l-methadone."1.34Characterization of the antinociceptive and pronociceptive effects of methadone in rats. ( Holtman, JR; Wala, EP, 2007)
" Equally important perioperative treatment principles are stabilization of physical dependence by substitution with methadone (for heroin addicts) or benzodiazepines/clonidine (for alcohol, sedatives and hypnotics addiction), avoidance of stress and craving, thorough intraoperative and postoperative stress relief by using regional techniques or systematically higher than normal dosages of anesthetics and opioids, strict avoidance of inadequate dosage of analgetics, postoperative optimization of regional or systemic analgesia by non-opioids and coanalgetics and consideration of the complex physical and psychological characteristics and comorbidities."1.33[Anesthesia and analgesia in addicts: basis for establishing a standard operating procedure]. ( Heid, F; Jage, J, 2006)
"Central to both pain responses and opioid addiction is activity at the micro -opioid receptor."1.32Association between human mu-opioid receptor gene polymorphism, pain tolerance, and opioid addiction. ( Alarcón, M; Compton, P; Geschwind, DH, 2003)
"This hyperalgesia is evident in people with a history of heroin use and is not modified by methadone or buprenorphine treatment but is reduced by long-term abstinence from opioids."1.32Pleasure into pain: the consequences of long-term opioid use. ( White, JM, 2004)
" to mice on an escalating three times per day dosing schedule resulted in a nearly 3-fold increase in the tail-flick ED50 dose of morphine which was prevented by s."1.30d-Methadone blocks morphine tolerance and N-methyl-D-aspartate-induced hyperalgesia. ( Davis, AM; Inturrisi, CE, 1999)

Research

Studies (36)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (5.56)18.2507
2000's19 (52.78)29.6817
2010's15 (41.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Larsen, IM1
Drewes, AM1
Olesen, AE1
Athanasos, P1
Ling, W5
Bochner, F4
White, JM6
Somogyi, AA7
Martin, DP1
Samora, WP1
Beebe, AC1
Klamar, J1
Gill, L1
Bhalla, T1
Veneziano, G1
Thung, A1
Tumin, D1
Barry, N1
Rice, J1
Tobias, JD1
Barelli, R1
Morelli Sbarra, G1
Sbaraglia, F1
Zappia, L1
Rossi, M1
Lamberts, JT1
Smith, CE1
Li, MH1
Ingram, SL1
Neubig, RR1
Traynor, JR1
Salpeter, SR2
Buckley, JS2
Bruera, E2
Craig, DS1
Aoki, Y1
Mizoguchi, H1
Watanabe, C1
Sakurada, T1
Sakurada, S1
Abreu, M1
Aguado, D1
Benito, J1
García-Fernández, J1
Segura, IA1
Compton, PA1
Torrington, MA2
Hutchinson, MR2
Coats, BD2
Lewis, SS2
Zhang, Y2
Sprunger, DB1
Rezvani, N2
Baker, EM1
Jekich, BM1
Wieseler, JL2
Martin, D1
Poole, S1
Judd, CM1
Maier, SF2
Watkins, LR2
Prommer, EE1
Hay, JL2
Semple, TJ1
Rounsefell, B1
Kaboutari, J1
Salem, A1
Irvine, R1
Compton, P2
Kehoe, P1
Sinha, K1
Yin, H1
Rice, KC1
Peles, E1
Schreiber, S1
Hetzroni, T1
Adelson, M1
Defrin, R1
Huxtable, CA1
Roberts, LJ1
MacIntyre, PE1
Clark, DJ1
Geschwind, DH1
Alarcón, M1
Drummond, PD1
de Silva-Rossdeutscher, E1
Chung, KS1
Carson, S1
Glassman, D1
Vadivelu, N1
Pérez Martínez, J1
Arguis Giménez, MJ1
Fernández Candil, JL1
Martínez Fernández, G1
Sinche Yupanqui, M1
Moreno Cuartas, LA1
Galard Hernández, JJ1
Gomar Sancho, C1
Streltzer, J1
Johansen, L1
Prommer, E1
Jage, J1
Heid, F1
Holtman, JR1
Wala, EP1
Davis, MP1
Shaiova, LA1
Angst, MS1
Prosser, JM1
Steinfeld, M1
Cohen, LJ1
Derbyshire, S1
Eisenberg, DP1
Cruciani, RA1
Galynker, II1
Sjøgren, P1
Jensen, NH1
Jensen, TS1
Davis, AM1
Inturrisi, CE1
Doverty, M2
Ali, R1
Beare, CH1
Menelaou, A1
Bulka, A1
Plesan, A1
Xu, XJ1
Wiesenfeld-Hallin, Z1

Clinical Trials (8)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Analgesia Following Posterior Spinal Fusion: Methadone vs Magnesium[NCT01795495]Phase 263 participants (Actual)Interventional2013-09-30Completed
A Prospective Study Comparing Total Intravenous Anesthesia With Propofol and Remifentanil vs. Propofol and Dexmedetomidine in Adolescent Idiopathic Scoliosis Patients Undergoing Posterior Spinal Fusion and Instrumentation[NCT06096181]Phase 2120 participants (Anticipated)Interventional2023-12-31Not yet recruiting
Opioid-Induced Hyperalgesia in Prescription Opioid Abusers: Effects of Pregabalin[NCT01821430]Phase 24 participants (Actual)Interventional2013-03-31Terminated (stopped due to poor recruitment)
Effect of Opioid Taper on Pain Responses in Patients With Chronic Pain[NCT03912298]7 participants (Actual)Observational2019-04-15Completed
A Double Blind, Randomized Clinical Trial Comparing Postoperative Narcotic Usage in Patients Receiving Periarticular Liposomal Bupivicaine vs. Those Patients Receiving Standard Periarticular Joint Injections[NCT02682498]Phase 438 participants (Actual)Interventional2013-10-31Completed
IRB-HSR# 14145 R,S Methadone: Analgesia and Pharmacokinetics in Adolescents Undergoing Scoliosis Correction[NCT01205256]Phase 311 participants (Actual)Interventional2009-03-31Completed
The Effect of Methadone vs. Fentanyl Administration on Postoperative Pain Control in Pediatric Patients Undergoing Cardiac Surgery: A Randomized, Double-Blinded Controlled Trial[NCT02747875]26 participants (Actual)Interventional2016-09-30Terminated (stopped due to Drug Shortage)
The Effects of Opioid Taper on Opioid-Induced Hyperalgesia[NCT03063905]15 participants (Actual)Observational2017-01-31Terminated (stopped due to funding expired)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Intra- and Post-operative Pain Relief

To prospectively compare the effects of intra-operative methadone and magnesium on postoperative opioid requirements. Total amount of hydromorphone administered in OR, recovery room (PACU), and on the inpatient ward 24 hours post-operatively. (NCT01795495)
Timeframe: Intra-operative and 24 hours post-operatively

Interventionmg/kg (Mean)
Remifentanil0.34
Remifentanil Plus Methadone0.26
Remifentanil Plus Magnesium0.38

Post-operative Pain Scores

VAS pain score - 0 being no pain and 10 being worst pain. (NCT01795495)
Timeframe: Post-operatively to 24 hours

Interventionunits on a scale (Mean)
Remifentanil4.6
Remifentanil Plus Methadone5.1
Remifentanil Plus Magnesium5.1

Conditioned Pain Modulation Measured Using the Quantitative Sensory Testing (QST)

Conditioned pain modulation will be measured using the quantitative sensory testing (QST) employing procedures consistent with those described in the literature to capture supra-spinal mechanisms of OIH. To detect conditioned modulation, the subject is asked to verbally report the severity of pain experienced on a visual analogue scale (0- no pain, 10-worst pain ever) to a three-second painful heat stimulus (47○C) delivered at 12-15 second intervals, in the presence or absence of the non-dominant limb being immerged in a cold-water bath (12○C). The reported value is the difference between the average of pain scores reported in the absence of vs. the presence of the counter-stimulation. Reported are changes in the conditioned pain modulation assay both prior to and following taper. Taper is individualized thus length of taper varies between subjects. (NCT03912298)
Timeframe: up to one year (individualized, variable taper length)

Interventionunits on a visual analogue scale (Mean)
pre-taper conditioned pain modulation (baseline)post taper conditioned pain modulation (individualized taper, thus time length varies)
Chronic Pain Patients Undergoing Opioid Taper-0.14-0.40

Pain Perception Measured Using the Cold-pressor Test (CPT)

Pain perception will be measured using the cold-pressor test (CPT) employing procedures consistent with those described in the literature. Order of pain testing will vary, and three aspects of the pain response will be captured at each study session: evoked pain; temporal summation; and conditioned pain modulation, which map on to the hypothesized peripheral, spinal and supra-spinal mechanisms of OIH. Reported are cold-pressor pain tolerance prior to and following taper. (NCT03912298)
Timeframe: up to one year (length of taper individualized and varies)

Interventionseconds (Mean)
pre taper pain tolerance (baseline)post-taper pain tolerance (timeframe variable)
Chronic Pain Patients Undergoing Opioid Taper24.0142.02

48 Hour Post-surgical Opioid Use

A comparison of group means between the control group and study group with regards to 48 hour opioid use. (NCT02682498)
Timeframe: 48 hours

Interventionmorphine equivalents (Mean)
EXPAREL® Bupivacaine Liposome Suspension5.32
Standard Periarticular Joint Injection5.07

Average Daily Opioid Use During Admission

Opioid use will be monitored daily from the time of admission in comparison of standard knee injection post-operatively. (NCT02682498)
Timeframe: Up to 48 hours

InterventionTotal Morphine Equivalents (Mean)
EXPAREL® Bupivacaine Liposome Suspension100
Standard Periarticular Joint Injection103

Average Daily Patient Pain Score

Examining the average daily patient pain score in comparison of standard knee injection post-operatively. The measure is the Visual-Analog-Scale (VAS) for subjective pain reporting. The minimum 0 (no pain) and the maximum is 10 (worst pain imagineable). There is only one measure in the scale (i.e. there are no subscales). Lower scores on the VAS scale equate to less pain and are therefore desirable. (NCT02682498)
Timeframe: Up to 48 hours

InterventionVisual Analog Scale Rating (Mean)
EXPAREL® Bupivacaine Liposome Suspension4.75
Standard Periarticular Joint Injection5.75

Post-operative Complications

Examining the post-operative complication in comparison of standard knee injection post-operatively. (NCT02682498)
Timeframe: Up to 1 month

Interventioncomplications (Number)
EXPAREL® Bupivacaine Liposome Suspension0
Standard Periarticular Joint Injection0

Recovery Room Opioid Use

Post anesthesia care unit (recovery room) opioid use in total mg morphine IV equivalent in comparison of standard knee injection post-operatively. (NCT02682498)
Timeframe: Up to 48 hours

InterventionTotal morphine equivalents (Median)
EXPAREL® Bupivacaine Liposome Suspension5
Standard Periarticular Joint Injection5

Total Opioid Dose, in Morphine Equivalents, in the First 24 Hours After Pediatric Cardiac Bypass Surgery.

The distribution of the total opioid dose in the first 24 hours will be evaluated by randomization group (methadone vs. fentanyl) and differences between groups will be tested. It is hypothesized that compared to fentanyl, methadone administered intraoperative will result in a significantly lower total opioid dose (morphine or oxycodone) during the first 24 hour postoperative period. Assuming no difference between the two treatment strategies in the population, a total sample size of 52 in each group will provide 80% power to detect an effect size of 0.1. Significance will be measured as a 30% reduction in postoperative pain requirement. (NCT02747875)
Timeframe: 24 hours

Interventionmg postop morphine equivelant 24hr (Mean)
Control - Fentanyl0.55
Treatment - Methadone0.48

Opioid-related Adverse Events Including: Respiratory Failure, Cardiovascular Instability, and Postoperative Nausea and Vomiting

Opioid-related adverse events will be monitored closely and a secondary analysis will compare the incidence of side effects between the two groups during the first 24-hour postoperative period. The Pearson's contingency chi-square test will be used to evaluate any differences between the randomization groups in opioid-related adverse events during the first 24-hour postoperative period. (NCT02747875)
Timeframe: 24 hours

,
Interventionevents (Mean)
Ondansetron DosesEmesis EpisodesHypoventilation EpisodesArrhythmias
Control - Fentanyl3.812.7200
Treatment - Methadone3.432.0800

Reviews

1 review available for methadone and Allodynia

ArticleYear
Acute pain management in opioid-tolerant patients: a growing challenge.
    Anaesthesia and intensive care, 2011, Volume: 39, Issue:5

    Topics: Acute Disease; Analgesics; Analgesics, Opioid; Animals; Australia; Buprenorphine; Buprenorphine, Nal

2011

Trials

7 trials available for methadone and Allodynia

ArticleYear
The Effect of a Combination of Diclofenac and Methadone Applied as Gel in a Human Experimental Pain Model - A Randomized, Placebo-controlled Trial.
    Basic & clinical pharmacology & toxicology, 2018, Volume: 123, Issue:2

    Topics: Administration, Cutaneous; Adult; Capsaicin; Chronic Pain; Cross-Over Studies; Diclofenac; Dose-Resp

2018
Analgesic effects of methadone and magnesium following posterior spinal fusion for idiopathic scoliosis in adolescents: a randomized controlled trial.
    Journal of anesthesia, 2018, Volume: 32, Issue:5

    Topics: Adolescent; Analgesics, Opioid; Desflurane; Female; Humans; Hyperalgesia; Magnesium; Male; Methadone

2018
Lack of effect of chronic dextromethorphan on experimental pain tolerance in methadone-maintained patients.
    Addiction biology, 2008, Volume: 13, Issue:3-4

    Topics: Adolescent; Adult; Analgesics, Opioid; Dextromethorphan; Double-Blind Method; Excitatory Amino Acid

2008
Gabapentin improves cold-pressor pain responses in methadone-maintained patients.
    Drug and alcohol dependence, 2010, Jun-01, Volume: 109, Issue:1-3

    Topics: Adult; Amines; Analgesics, Non-Narcotic; Cold Temperature; Cyclohexanecarboxylic Acids; Double-Blind

2010
Transcutaneous iontophoresis of methadone provokes local flushing and thermal hyperalgesia.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2003, Volume: 52, Issue:9

    Topics: Administration, Cutaneous; Adolescent; Adult; Female; Flushing; Hot Temperature; Humans; Hyperalgesi

2003
Hyperalgesic responses in methadone maintenance patients.
    Pain, 2001, Feb-01, Volume: 90, Issue:1-2

    Topics: Adult; Cold Temperature; Confidence Intervals; Electric Stimulation; Female; Humans; Hyperalgesia; M

2001
Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine.
    Pain, 2001, Volume: 93, Issue:2

    Topics: Acute Disease; Adult; Analgesics, Opioid; Cold Temperature; Drug Interactions; Drug Tolerance; Elect

2001

Other Studies

28 other studies available for methadone and Allodynia

ArticleYear
Buprenorphine Maintenance Subjects Are Hyperalgesic and Have No Antinociceptive Response to a Very High Morphine Dose.
    Pain medicine (Malden, Mass.), 2019, 01-01, Volume: 20, Issue:1

    Topics: Adult; Analgesics, Opioid; Buprenorphine; Drug Tolerance; Female; Humans; Hyperalgesia; Injections,

2019
Prevention of post-operative hyperalgesia in a heroin-addicted patient on methadone maintenance.
    Journal of clinical pharmacy and therapeutics, 2019, Volume: 44, Issue:3

    Topics: Analgesics, Opioid; Heroin; Humans; Hyperalgesia; Ketamine; Male; Methadone; Middle Aged; Opioid-Rel

2019
Differential control of opioid antinociception to thermal stimuli in a knock-in mouse expressing regulator of G-protein signaling-insensitive Gαo protein.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2013, Mar-06, Volume: 33, Issue:10

    Topics: Analgesics, Opioid; Animals; Brain; Diprenorphine; Dose-Response Relationship, Drug; Electric Stimul

2013
The use of very-low-dose methadone for palliative pain control and the prevention of opioid hyperalgesia.
    Journal of palliative medicine, 2013, Volume: 16, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; California; Dose-Response Relationship, Drug; Ex

2013
Very-low-dose methadone: authors' response.
    Journal of palliative medicine, 2013, Volume: 16, Issue:10

    Topics: Analgesics, Opioid; Dose-Response Relationship, Drug; Female; Hospice Care; Humans; Hyperalgesia; Ma

2013
Very-low-dose methadone for the prevention of opioid hyperalgesia.
    Journal of palliative medicine, 2013, Volume: 16, Issue:10

    Topics: Analgesics, Opioid; Dose-Response Relationship, Drug; Female; Hospice Care; Humans; Hyperalgesia; Ma

2013
Differential alternation of the antinociceptive effect of narcotic analgesics on the inflammatory pain state.
    Neuroscience letters, 2014, Feb-07, Volume: 560

    Topics: Animals; Fentanyl; Freund's Adjuvant; Hyperalgesia; Inflammation; Male; Methadone; Mice; Narcotics;

2014
Hyperalgesia and increased sevoflurane minimum alveolar concentration induced by opioids in the rat: a randomised experimental study.
    European journal of anaesthesiology, 2015, Volume: 32, Issue:4

    Topics: Analgesics, Opioid; Anesthetics, Inhalation; Animals; Behavior, Animal; Buprenorphine; Hyperalgesia;

2015
Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia.
    Brain, behavior, and immunity, 2008, Volume: 22, Issue:8

    Topics: Analgesia; Analgesics, Opioid; Animals; Catheters, Indwelling; Chemokine CX3CL1; Cytokines; Hyperalg

2008
Opioid-induced pain.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Jul-10, Volume: 26, Issue:20

    Topics: Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans;

2008
Hyperalgesia in opioid-managed chronic pain and opioid-dependent patients.
    The journal of pain, 2009, Volume: 10, Issue:3

    Topics: Adult; Analgesics, Opioid; Chronic Disease; Drug Tolerance; Female; Humans; Hyperalgesia; Male; Meth

2009
Model of methadone-induced hyperalgesia in rats and effect of memantine.
    European journal of pharmacology, 2010, Jan-25, Volume: 626, Issue:2-3

    Topics: Animals; Behavior, Animal; Disease Models, Animal; Hyperalgesia; Male; Memantine; Methadone; Rats; R

2010
Possible involvement of toll-like receptor 4/myeloid differentiation factor-2 activity of opioid inactive isomers causes spinal proinflammation and related behavioral consequences.
    Neuroscience, 2010, May-19, Volume: 167, Issue:3

    Topics: Analgesics, Opioid; Animals; Gliosis; Hyperalgesia; Immunity, Innate; Inflammation; Inflammation Med

2010
The differential effect of methadone dose and of chronic pain on pain perception of former heroin addicts receiving methadone maintenance treatment.
    The journal of pain, 2011, Volume: 12, Issue:1

    Topics: Adult; Analgesics, Opioid; Analysis of Variance; Chronic Disease; Dose-Response Relationship, Drug;

2011
Comment on: Doverty et al, Hyperalgesic responses in methadone maintenance patients (Pain 2001;90;91-6).
    Pain, 2002, Volume: 99, Issue:3

    Topics: Animals; Humans; Hyperalgesia; Methadone; Opioid-Related Disorders; Pain Threshold; Patients

2002
Association between human mu-opioid receptor gene polymorphism, pain tolerance, and opioid addiction.
    American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 2003, Aug-15, Volume: 121B, Issue:1

    Topics: Humans; Hyperalgesia; Methadone; Opioid-Related Disorders; Polymorphism, Genetic; Receptors, Opioid,

2003
Pleasure into pain: the consequences of long-term opioid use.
    Addictive behaviors, 2004, Volume: 29, Issue:7

    Topics: Analgesics, Opioid; Drug Tolerance; Humans; Hyperalgesia; Methadone; Mood Disorders; Narcotics; Sens

2004
Successful treatment of hydromorphone-induced neurotoxicity and hyperalgesia.
    Connecticut medicine, 2004, Volume: 68, Issue:9

    Topics: Humans; Hydromorphone; Hyperalgesia; Male; Methadone; Middle Aged; Narcotics; Neurotoxicity Syndrome

2004
[Intrathecal methadone for cancer pain after vulvectomy].
    Revista espanola de anestesiologia y reanimacion, 2004, Volume: 51, Issue:9

    Topics: Analgesics, Opioid; Carcinoma; Combined Modality Therapy; Female; Humans; Hyperalgesia; Hysterectomy

2004
Prescription drug dependence and evolving beliefs about chronic pain management.
    The American journal of psychiatry, 2006, Volume: 163, Issue:4

    Topics: Adult; Analgesics, Opioid; Chronic Disease; Drug Prescriptions; Drug Tolerance; Drug Utilization; Fe

2006
Rotating methadone to other opioids: a lesson in the mechanisms of opioid tolerance and opioid-induced pain.
    Journal of palliative medicine, 2006, Volume: 9, Issue:2

    Topics: Adult; Drug Tolerance; Humans; Hyperalgesia; Male; Methadone; Narcotics; Pain; Receptors, N-Methyl-D

2006
[Anesthesia and analgesia in addicts: basis for establishing a standard operating procedure].
    Der Anaesthesist, 2006, Volume: 55, Issue:6

    Topics: Analgesics; Analgesics, Opioid; Anesthesia; Diagnosis, Dual (Psychiatry); Drug Tolerance; Humans; Hy

2006
Characterization of the antinociceptive and pronociceptive effects of methadone in rats.
    Anesthesiology, 2007, Volume: 106, Issue:3

    Topics: Analgesics, Opioid; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hot T

2007
Characterization of the antinociceptive and pronociceptive effects of methadone in rats.
    Anesthesiology, 2007, Volume: 106, Issue:3

    Topics: Analgesics, Opioid; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hot T

2007
Characterization of the antinociceptive and pronociceptive effects of methadone in rats.
    Anesthesiology, 2007, Volume: 106, Issue:3

    Topics: Analgesics, Opioid; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hot T

2007
Characterization of the antinociceptive and pronociceptive effects of methadone in rats.
    Anesthesiology, 2007, Volume: 106, Issue:3

    Topics: Analgesics, Opioid; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hot T

2007
When opioids cause pain.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Oct-01, Volume: 25, Issue:28

    Topics: Analgesics, Opioid; Back Pain; Carcinoma, Hepatocellular; Drug Therapy, Combination; Fentanyl; Human

2007
Abnormal heat and pain perception in remitted heroin dependence months after detoxification from methadone-maintenance.
    Drug and alcohol dependence, 2008, Jun-01, Volume: 95, Issue:3

    Topics: Adult; Demography; Diagnostic and Statistical Manual of Mental Disorders; Differential Threshold; Fe

2008
Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with other opioid agonists.
    Pain, 1994, Volume: 59, Issue:2

    Topics: Adult; Aged; Analgesics, Opioid; Child; Delayed-Action Preparations; Female; Humans; Hyperalgesia; M

1994
d-Methadone blocks morphine tolerance and N-methyl-D-aspartate-induced hyperalgesia.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 289, Issue:2

    Topics: Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Drug Tolerance; Excitatory Amino Acid

1999
d-Methadone blocks morphine tolerance and N-methyl-D-aspartate-induced hyperalgesia.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 289, Issue:2

    Topics: Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Drug Tolerance; Excitatory Amino Acid

1999
d-Methadone blocks morphine tolerance and N-methyl-D-aspartate-induced hyperalgesia.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 289, Issue:2

    Topics: Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Drug Tolerance; Excitatory Amino Acid

1999
d-Methadone blocks morphine tolerance and N-methyl-D-aspartate-induced hyperalgesia.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 289, Issue:2

    Topics: Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Drug Tolerance; Excitatory Amino Acid

1999
Reduced tolerance to the anti-hyperalgesic effect of methadone in comparison to morphine in a rat model of mononeuropathy.
    Pain, 2002, Volume: 95, Issue:1-2

    Topics: Analgesics, Opioid; Animals; Disease Models, Animal; Drug Tolerance; Hyperalgesia; Male; Methadone;

2002